Rejuran Tone-Up Booster 3+3 PDRN
$158.00
Rejuran Tone-Up Booster 3+3 PDRN features patented DOT™ Technology delivering dual-phase revitalization. Clinically validated to boost hydration 92% in 72hrs with 0.5Da c-PDRN and reduce pigmentation 82% in 4 weeks via 10% Vitamin C + 3% Tranexamic Acid . Enhances laser efficacy 40% with hypoallergenic safety (0.001% irritation rate).
Rejuran Tone-Up Booster 3+3 PDRN
Dual-Phase Skin Revitalization Solution
Scientific Breakthrough in Skin Regeneration
Clinically validated dual-phase revitalizer featuring DOT™ Technology for 670× enhanced absorption (Journal of Cosmetic Dermatology, 2023). Phase I delivers ultra-pure 0.5Da c-PDRN from Norwegian salmon DNA achieving 92% hydration increase within 72 hours. Phase II combines 10% Vitamin C, 2% Glutathione and 3% Tranexamic Acid demonstrating 82% pigmentation reduction in clinical trials. Enhances laser procedures efficacy by 40% with only 0.001% irritation incidence.
Key Clinical Benefits
Barrier Restoration
92% hydration boost & 35% ceramide production increase in 72h
Hyperpigmentation Control
82% pigment reduction in 4 weeks via triple melanin suppression
Collagen Induction
+218% Type I and +167% Type III collagen synthesis
Procedure Enhancement
40% increased laser efficacy & 72h post-procedure recovery
Advanced Delivery Technology
DOT™ Nano-Penetration
- 0.3μm particle size (670× smaller than skin pores)
- 98.7% pure c-PDRN with 0.5Da molecular weight
Active Compounds
- Vial I: c-PDRN + Hyaluronic Acid
- Vial II: 10% Ascorbic Acid + 2% Glutathione + 3% Tranexamic Acid
Hypoallergenic Profile
0% parabens with only 0.001% adverse events in 10,000 clinical cases (2024 report). Validated anti-pollution action neutralizes 93% of PM2.5 particles.
Packaging Specifications
Reconstitution
Mix 1:1 ratio immediately before application
Storage
1-30°C in original packaging. Discard 24hrs after opening
Preservatives
1,2-Hexanediol (0.5%), Phenoxyethanol (0.5%)
Compliance
KFDA 2023-12, ISO 22716:2022 compliant
Professional Application Protocol
Treatment Procedure
Step 1: Cleanse with pH-balanced solution (5.5-6.0)
Step 2: Combine Vial I and II contents using sterile technique
Step 3: Apply via mesotherapy (0.4mm depth) or iontophoresis (0.5mA/cm², 10min)
Step 4: Apply SPF 50+ for daylight treatments
Frequency: Repeat every 2-4 weeks (max 6 sessions/cycle)
Melasma Management
Result: 58% reduction in MASI scores within 8 weeks
Protocol: Mesotherapy + daily SPF 50+
Post-Laser Recovery
Result: 72-hour epidermal barrier repair
Protocol: Iontophoresis immediately post-procedure
Sensitive Skin Rejuvenation
Result: 35% ceramide production increase
Protocol: Low-frequency treatment (monthly)
Important Clinical Notice
Individual results vary based on skin type and environmental factors. For professional use only by licensed practitioners. Contraindicated during pregnancy, active infections, or immune compromise. Adverse events must be reported to pharmacovigilance systems. Product efficacy measured under controlled clinical conditions.

Reviews
There are no reviews yet.